安全采血针市场规模、份额、成长分析（按产品类型、应用、最终用户和地区）- 2025 年至 2032 年产业预测

Safety Lancet Market Size, Share, and Growth Analysis, By Product Type (Push Button Safety Lancet, Pressure Activated Safety Lancet), By Application (Blood Glucose Testing, Haemoglobin Testing), By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年安全采血针市场规模将达到 17.4 亿美元，并从 2024 年的 19.1 亿美元成长到 2032 年的 39.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.5%。

受糖尿病和感染疾病病率上升的推动，安全采血针市场正在经历显着增长。作为血糖值监测和诊断测试的重要工具，采血针正成为医疗保健不可或缺的一部分。市场对更安全、更方便、更容易使用的一次性采血针的需求越来越大。由于医疗设施的增加和健康意识的增强，印度和中国等新兴市场已具备扩张的条件。然而，市场也面临挑战，包括对针刺伤的担忧，这会对医护人员带来感染疾病传播的风险。此外，重复使用采血针的感染风险凸显了在医疗实践中转变为一次性采血针的更安全选择。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）
  主要企业简介
  - 康德乐（美国）
  - Greiner Bio-One International GmbH（奥地利）
  - Sarstedt AG & Co. KG（德国）
  - 尼普洛株式会社（日本）
  - 阳普医疗科技有限公司 (中国)
  - 简单诊断（美国）
  - Ypsomed AG（瑞士）
  - 欧文芒福德有限公司（英国）
  - Arkray株式会社（日本）
  - Perrigo Company plc（爱尔兰）
  - 史密斯医疗公司（美国）
  - Medline Industries, Inc.（美国）
  - 欧姆龙健康照护株式会社（日本）
  - F. Hoffmann-La Roche AG（瑞士）
  - Trinity BIoTech（爱尔兰）
  - Microdot Healthcare（英国）
  - MED TRUST控股公司（奥地利）
  - Nemaura Medical Inc.（英国）

结论和建议

简介目录

Product Code: SQMIG35A2818

Safety Lancet Market size was valued at USD 1.74 billion in 2023 and is poised to grow from USD 1.91 billion in 2024 to USD 3.94 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The safety lancet market is experiencing significant growth, fueled by the rising incidence of diabetes and infectious diseases. As critical tools for blood glucose monitoring and diagnostic testing, lancets are becoming essential in healthcare. The market is increasingly driven by the demand for user-friendly, single-use lancets that offer greater safety and convenience. Emerging markets such as India and China are ripe for expansion, thanks to an increasing number of healthcare facilities and heightened health awareness. However, the market faces challenges, including concerns over needlestick injuries that risk infectious disease transmission among healthcare workers. Furthermore, the risk of infection from reused lancets underscores the shift toward single-use options as a safer choice in healthcare practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Safety Lancet market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Safety Lancet Market Segments Analysis

Global Safety Lancet Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. Based on Application, the market is segmented into Blood Glucose Testing, Haemoglobin Testing, Cholesterol Testing and Coagulation Testing. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Safety Lancet Market

The safety lancet market is experiencing significant growth driven by the rising prevalence of diabetes, a health concern projected to double over the next quarter-century. This increase is largely due to the escalating rates of both type 1 and type 2 diabetes, which place considerable strain on global healthcare systems. Factors contributing to the rise in diabetes include lifestyle choices such as obesity, sedentary habits, smoking, and urbanization. The aging population also plays a crucial role, as older individuals are more susceptible to diabetes. Consequently, the growing need for effective diabetes management solutions will likely lead to a higher adoption of safety lancets in the coming years.

Restraints in the Safety Lancet Market

The safety lancet market encounters significant challenges to its growth primarily due to the limited awareness surrounding homecare lancets, especially in developing countries worldwide. This lack of knowledge presents a considerable barrier, as it restricts the adoption of these essential devices by individuals who could greatly benefit from their use for various diagnostic and monitoring applications. As potential users remain uninformed about the advantages and functionalities of homecare lancets, the market struggles to reach its full potential, hindering efforts to improve health outcomes through enhanced accessibility to necessary medical tools. Addressing this awareness gap is crucial for market expansion.

Market Trends of the Safety Lancet Market

The safety lancet market is witnessing robust growth, propelled by ongoing technological advancements and an increasing emphasis on patient safety. Innovations in design, such as retractable lancets that automatically shield the needle post-use, are becoming pivotal in minimizing needlestick injuries and enhancing user confidence. This trend is further supported by rising awareness around safe blood sampling practices and stringent regulatory standards mandating the use of safer medical devices. Additionally, the growing prevalence of diabetes and other chronic conditions necessitating regular blood glucose monitoring is driving demand. Collectively, these factors are forging a dynamic landscape for the safety lancet market through 2023 and beyond.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Safety Lancet Market Size by Product Type & CAGR (2025-2032)

Market Overview
Push Button Safety Lancet
Pressure Activated Safety Lancet
Side Button Safety Lancet

Global Safety Lancet Market Size by Application & CAGR (2025-2032)

Market Overview
Blood Glucose Testing
Haemoglobin Testing
Cholesterol Testing
Coagulation Testing

Global Safety Lancet Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals and Clinics
Diagnostic Centers and Pathology Laboratories
Home Diagnostics
Others

Global Safety Lancet Market Size & CAGR (2025-2032)

North America (Product Type, Application, End User)
- US
- Canada
Europe (Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarstedt AG & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Improve Medical Technology Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Simple Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smiths Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omron Healthcare, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microdot Healthcare (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MED TRUST Holding Co. (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemaura Medical Inc. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments